Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

3.08
Delayed Data
As of 4:00pm ET
 -0.05 / -1.60%
Today’s Change
2.96
Today|||52-Week Range
19.43
-77.30%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close3.13
Today’s open3.15
Day’s range3.05 - 3.20
Volume2,114,104
Average volume (3 months)1,803,525
Market cap$276.9M
Dividend yield--
Data as of 4:00pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.62%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book7.84

Competitors

 Today’s
change
Today’s
% change
EDGEEdge Therapeutics In...+0.29+2.95%
VYGRVoyager Therapeutics...+0.36+3.39%
CYADCelyad SA-1.22-4.66%
NSTGNanoString Technolog...+0.19+1.53%
Data as of 4:00pm ET, 06/30/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs